Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis
NCT07347626
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
786
Enrollment
OTHER
Sponsor class
Conditions
Acute Ischemic Stroke
Interventions
DRUG:
Eptifibatide (Integrilin)
DRUG:
Standard Medical Therapy
Sponsor
Xinqiao Hospital of Chongqing
Collaborators
[object Object]
[object Object]